![American Society of Clinical Oncology American Society of Clinical Oncology](https://54d4f314-8f94-415c-acb7-fd0a6332f070.s3.amazonaws.com/403/403__asco-logo-lg__274272709.png?X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIAU2BE4PNFKE2WZV7V%2F20240727%2Fus-east-1%2Fs3%2Faws4_request&X-Amz-Date=20240727T052927Z&X-Amz-SignedHeaders=host&X-Amz-Expires=86400&X-Amz-Signature=73f1482bc25aa3742d139d36289727f415968a8f0005b94f7f2b6954b6ade48c)
Resected Biliary Tract Cancer
Publication Date: March 11, 2019
Key Points
Key Points
Biliary tract cancers usually present at an advanced stage, and only approximately 20% of tumors are considered resectable.
Surgery is the primary curative treatment option for early-stage biliary tract cancer. However, due to the high rates of recurrence with resection alone, there remains a need for effective adjuvant therapy to improve rates of relapse-free and overall survival while maintaining health-related quality of life.
Surgery is the primary curative treatment option for early-stage biliary tract cancer. However, due to the high rates of recurrence with resection alone, there remains a need for effective adjuvant therapy to improve rates of relapse-free and overall survival while maintaining health-related quality of life.
Treatment
Treatment
...resected biliary tract cancer shou...
...with extrahepatic cholangiocarcinoma or gallbla...